$PLXS earnings report

Plexus reported fiscal fourth-quarter revenue of $1.427 billion, GAAP operating margin of 6.0% and GAAP diluted EPS of $2.51, and initiated fiscal first-quarter 2027 revenue guidance of $1.410 billion to $1.460 billion. AlphAI read Plexus's Fiscal fourth quarter and fiscal year 2026 filing as strong.

Fiscal fourth quarter and fiscal year 2026

AlphAI · Earnings readPLXS · Fiscal fourth quarter and fiscal year 2026 · ended October 3, 2026

Plexus reported fiscal fourth-quarter revenue of $1.427 billion, GAAP operating margin of 6.0% and GAAP diluted EPS of $2.51, and initiated fiscal first-quarter 2027 revenue guidance of $1.410 billion to $1.460 billion.

✓Strong quarter

Fourth-quarter revenue, GAAP operating margin, GAAP diluted EPS, non-GAAP operating margin and adjusted EPS all exceeded the company’s Q4F26 guidance ranges. Fiscal 2026 revenue reached $4.965 billion and non-GAAP operating margin reached 6.2%, while first-quarter guidance calls for further revenue growth.

Revenue
$1.43B
Americas, three months ended October 3, 2026
$456M
Gross margin · GAAP
10.2%
EPS · non-GAAP
$2.84
Fiscal first quarter ending January 2, 2027; fiscal 2027 selected outlook outlook
$1.410 billion to $1.460 billion

Key metrics

shortened, hover for the filing’s print
MetricValueq/qy/y
Revenue, three months ended October 3, 2026GAAP$1.43B––
Revenue, twelve months ended October 3, 2026GAAP$4.96B–23% year-over-year growth
Gross profit, three months ended October 3, 2026GAAP$146.0M––
Gross profit, twelve months ended October 3, 2026GAAP$502.7M––
Gross margin, three months ended October 3, 2026GAAP10.2%––
Gross margin, twelve months ended October 3, 2026GAAP10.1%––
Selling and administrative expenses, three months ended October 3, 2026GAAP$59.7M––
Selling and administrative expenses, twelve months ended October 3, 2026GAAP$238.8M––
Operating income, three months ended October 3, 2026GAAP$86.28M––
Operating income, twelve months ended October 3, 2026GAAP$263.8M––
Operating margin, three months ended October 3, 2026GAAP6.0%––
Operating margin, twelve months ended October 3, 2026GAAP5.3%––
Net income, three months ended October 3, 2026GAAP$68.51M––
Net income, twelve months ended October 3, 2026GAAP$202.5M––
Basic EPS, three months ended October 3, 2026GAAP$2.57––
Basic EPS, twelve months ended October 3, 2026GAAP$7.58––
Diluted EPS, three months ended October 3, 2026GAAP$2.51––
Diluted EPS, twelve months ended October 3, 2026GAAP$7.41––
Non-GAAP operating income, three months ended October 3, 2026non-GAAP$95.84M––
Non-GAAP operating income, twelve months ended October 3, 2026non-GAAP$310.2M––
Non-GAAP operating margin, three months ended October 3, 2026non-GAAP6.7%––
Non-GAAP operating margin, twelve months ended October 3, 2026non-GAAP6.2%––
Adjusted net income, three months ended October 3, 2026non-GAAP$77.33M––
Adjusted net income, twelve months ended October 3, 2026non-GAAP$245.1M––
Adjusted diluted EPS, three months ended October 3, 2026non-GAAP$2.84––
Adjusted diluted EPS, twelve months ended October 3, 2026non-GAAP$8.97––
ROIC, fiscal year 2026non-GAAP15.8%––
Economic return, fiscal year 2026non-GAAP6.8%––
Free cash flow, three months ended October 3, 2026non-GAAP$6.4M––
Free cash flow, fiscal year ended October 3, 2026non-GAAPusage of free cash flow of $28.9 million––
Cash flows provided by operating activities, twelve months ended October 3, 2026GAAP$68.2M––
Capital expenditures, twelve months ended October 3, 2026other$97.1M––
Annualized cash cycle, three months ended October 3, 2026other62––
Top 10 customers as a percentage of revenue, fourth quarter fiscal 2026other56%up 1 percentage pointup 7 percentage points
Top 10 customers as a percentage of revenue, fiscal 2026other54%–up 5 percentage points

Segments

SegmentRevenueq/qy/y
Americas, three months ended October 3, 2026$456M––
Asia-Pacific, three months ended October 3, 2026$861M––
Europe, Middle East and Africa, three months ended October 3, 2026$115M––
Aerospace/Defense, three months ended October 3, 2026$224M––
Healthcare/Life Sciences, three months ended October 3, 2026$512M––
Industrial, three months ended October 3, 2026$691M––
Americas, twelve months ended October 3, 2026$1.63B––
Asia-Pacific, twelve months ended October 3, 2026$2.90B––
Europe, Middle East and Africa, twelve months ended October 3, 2026$458M––
Aerospace/Defense, twelve months ended October 3, 2026$847M––
Healthcare/Life Sciences, twelve months ended October 3, 2026$1.93B––
Industrial, twelve months ended October 3, 2026$2.19B––

Amounts quoted below without a unit are in thousands, as in the filing’s tables. Per-share figures are as printed.

Fiscal first quarter ending January 2, 2027; fiscal 2027 selected outlook outlook

  • Revenue$1.410 billion to $1.460 billion
  • NoteGAAP operating margin: 5.5% to 5.9%
  • NoteGAAP diluted EPS: $2.16 to $2.32, including $0.30 of stock-based compensation expense
  • NoteNon-GAAP operating margin: 6.0% to 6.4%
  • NoteNon-GAAP diluted EPS: $2.46 to $2.62, excluding stock-based compensation expense
  • NoteFiscal 2027 revenue growth: mid- to upper-teens
  • NoteFiscal 2027 operating margin: increasing operating margin
  • NoteFiscal 2027 cash cycle days: low to mid 60s
  • NoteFiscal 2027 free cash flow: at least $100 million
  • NoteNew non-GAAP operating margin goal: 6.5% to 7.0%

Capital returns

  • Purchased $21.4 million of shares at an average price of $254.32 per share in the fiscal fourth quarter, completing the 2026 Share Repurchase Program.
  • Purchased $85.0 million of shares at an average price of $199.68 per share in fiscal 2026.
  • The Board approved the 2027 Share Repurchase Program in August 2026 for an additional $100 million. The entirety of the program is available to begin fiscal 2027.

What drove it

  • The company won 36 manufacturing programs representing $290 million in annualized revenue when fully ramped into production.
  • Management cited stronger end-market demand and new program ramps for fourth-quarter performance.
  • Management cited significant revenue growth, operational efficiency investments and continuous improvement culture for fiscal 2026 non-GAAP operating margin of 6.2%.
  • Management said all market sectors delivered strong performance and secured new customer programs and relationships.
  • The funnel of qualified opportunities expanded by $1.2 billion year over year, or 33%, to $4.9 billion.
  • Industrial generated $691 million of fourth-quarter revenue, Healthcare/Life Sciences generated $512 million, and Aerospace/Defense generated $224 million.

Concerns

  • Top 10 customers comprised 56% of fourth-quarter revenue, up 1 percentage point from the third quarter of fiscal 2026 and up 7 percentage points from the fourth quarter of fiscal 2025.
  • Fiscal 2026 generated a usage of free cash flow of $28.9 million, as cash flows provided by operations of $68.2 million were less than capital expenditures of $97.1 million.
  • Inventories were $1,674,611 at October 3, 2026, compared with $1,229,839 at September 27, 2025.
  • Management anticipates a typical seasonal increase in cash cycle days for fiscal first quarter 2027.

What to watch

  • Execution against fiscal first-quarter revenue guidance of $1.410 billion to $1.460 billion and non-GAAP operating margin guidance of 6.0% to 6.4%.
  • Progress toward fiscal 2027 mid- to upper-teens revenue growth, increasing operating margin, low- to mid-60s cash cycle days and at least $100 million of free cash flow.
  • Conversion of $290 million in quarterly annualized manufacturing wins and the $4.9 billion qualified opportunity funnel into production revenue.
  • Customer concentration after the top 10 customers reached 56% of fourth-quarter revenue.
  • Progress toward the new non-GAAP operating margin goal of 6.5% to 7.0%.

Balance sheet and cash flow

  • Cash and cash equivalents were $281,176 at October 3, 2026, compared with $306,464 at September 27, 2025.
  • Current portion of long-term debt and finance lease obligations was $179,515 at October 3, 2026, compared with $45,793 at September 27, 2025.
  • Long-term debt and finance lease obligations, net of current portion, were $81,236 at October 3, 2026, compared with $91,987 at September 27, 2025.
  • Cash flows provided by operating activities were $68,200 for the twelve months ended October 3, 2026, compared with $249,231 for the twelve months ended September 27, 2025.
  • Payments for property, plant and equipment were $97,137 for the twelve months ended October 3, 2026, compared with $95,264 for the twelve months ended September 27, 2025.
  • Accounts receivable were $938,973, contract assets were $193,753, inventories were $1,674,611, accounts payable were $1,132,392, and advanced payments from customers were $690,608 at October 3, 2026.
  • Annualized cash cycle was 62 days in the fourth quarter, unchanged from the third quarter and compared with 63 days in the fourth quarter of fiscal 2025.

Analysis

Plexus completed fiscal 2026 with fourth-quarter revenue of $1,426,570, compared with $1,058,366 in the prior-year quarter and $1,304,778 in the preceding quarter. Fiscal-year revenue was $4,964,957 versus $4,032,966 in fiscal 2025. The company stated that fourth-quarter results exceeded its guidance ranges, with revenue of $1.427 billion against Q4F26 guidance of $1.330 billion to $1.380 billion, GAAP operating margin of 6.0% against guidance of 5.5% to 5.9%, and GAAP diluted EPS of $2.51 against guidance of $2.18 to $2.34.

Margins strengthened in the quarter. Gross margin was 10.2%, compared with 9.9% in the prior-year quarter and 10.1% in the preceding quarter. GAAP operating margin was 6.0%, compared with 5.0% and 4.7%, respectively. Non-GAAP operating margin was 6.7%, compared with 5.8% in the prior-year quarter and 6.3% in the preceding quarter. Non-GAAP operating income was $95,841 and adjusted diluted EPS was $2.84, with stock-based compensation, net of tax, of $0.33 per diluted share excluded from adjusted EPS.

Growth was broad across the reported market sectors in dollar terms. Fourth-quarter Industrial revenue was $691 million, Healthcare/Life Sciences revenue was $512 million, and Aerospace/Defense revenue was $224 million. Asia-Pacific produced $861 million of fourth-quarter revenue, Americas produced $456 million, and Europe, Middle East and Africa produced $115 million. Management tied the performance to stronger end-market demand, program ramps, 36 manufacturing-program wins representing $290 million in annualized revenue when fully ramped, and a qualified-opportunity funnel of $4.9 billion.

Cash conversion remained an area of attention. Fourth-quarter free cash flow was $6.4 million, comprising $29.2 million of cash flows provided by operations less $22.8 million of capital expenditures. Fiscal-year cash flows provided by operating activities were $68,200 and payments for property, plant and equipment were $97,137, resulting in a usage of free cash flow of $28.9 million. Annualized cash cycle was 62 days, while inventories were $1,674,611 at year-end. The company also repurchased $85.0 million of shares during fiscal 2026 and has an additional $100 million repurchase program available to begin fiscal 2027.

For fiscal first quarter 2027, Plexus guided revenue to $1.410 billion to $1.460 billion, GAAP operating margin to 5.5% to 5.9%, GAAP diluted EPS to $2.16 to $2.32, non-GAAP operating margin to 6.0% to 6.4%, and non-GAAP diluted EPS to $2.46 to $2.62. Management also expects fiscal 2027 mid- to upper-teens revenue growth, increasing operating margin, cash cycle days in the low to mid 60s, and at least $100 million of free cash flow. The company introduced a new non-GAAP operating margin goal of 6.5% to 7.0%.

Management, verbatim

Plexus delivered an outstanding fiscal 2026 that exceeded expectations, achieving record revenue of $5 billion, representing 23% year-over-year growth, and non-GAAP operating margin of 6.2%. In addition, ROIC surpassed our 15% enduring goal, supported by exceptional working capital performance. Finally, fiscal fourth quarter revenue of $1.43 billion, non-GAAP operating margin of 6.7% and non-GAAP EPS of $2.84 all exceeded guidance ranges as our team effectively captured stronger end-market demand and continued to support new program ramps.

Todd Kelsey, President and Chief Executive Officer

Plexus leveraged significant revenue growth, and the dividends from our ongoing operational efficiency investments and continuous improvement culture, to drive fiscal 2026 non-GAAP operating margin of 6.2%. Having consistently exceeded our previous 6% goal, we are introducing a new non-GAAP operating margin goal of 6.5% to 7.0%.

David Abuhl, Senior Vice President and Chief Financial Officer

Amidst further revenue growth acceleration, working capital discipline was outstanding, with a fiscal fourth quarter cash cycle of 62 days. While we anticipate a typical seasonal increase in cash cycle days for our fiscal first quarter, we remain focused on delivering cash cycle days in the low to mid 60s for fiscal 2027. Furthermore, we continue to expect to generate at least $100 million in fiscal 2027 free cash flow, driven by our robust profitability, strong working capital efficiency and disciplined capital investment.

David Abuhl, Senior Vice President and Chief Financial Officer

Not in the filing

stated, not guessed
  • Prior outlook section was not provided; therefore no comparison of reported results with prior guidance is included.
  • Fiscal first-quarter 2027 gross margin guidance was not reported.
  • Fiscal first-quarter 2027 operating-expense guidance was not reported.
  • Fiscal first-quarter 2027 tax-rate guidance was not reported.
  • A cash dividend declaration or dividend payment was not reported.
  • Quarterly cash flows provided by operating activities and quarterly capital expenditures for the prior-year and prior-quarter comparative periods were not reported.
  • Year-over-year and sequential percentage changes for individual geographic business segments and market sectors were not reported.

Written by an AI language model from the company’s SEC earnings filing (Form 8-K Item 2.02, or Form 6-K for a foreign private issuer). Every figure is checked against the filing text, and a metric the filing does not print, or whose value, prior period and change do not add up, is dropped from the metrics. The model can still misread a table, in the metrics or in the text, so check a number in the filing before you rely on it. Consensus estimates, price targets and share-price reactions are not shown because they are not in the filing. AI-generated research, not investment advice.

Questions about PLXS earnings dates

When is Plexus's next earnings date?
AlphAI has no date for PLXS yet. We do not publish estimates, so this page shows a date the day we have one.
Why is there sometimes no date?
AlphAI leaves out estimates. Many sites fill the gap by adding about 91 days to the last report, but that arithmetic is a guess, and a wrong date costs a reader more than a missing one, so we show nothing until a date is set, and a company can still move it. Every quarter already on this page is read straight from the SEC filing: an 8-K item 2.02 for US filers, a 6-K earnings release for foreign private issuers.